The successful candidate will provide evidence-based pharmacologic and psychotherapeutic treatment for substance use disorders, including medication treatment for opioid use disorder and other substance use disorders, while participating in a multidisciplinary academic environment that emphasizes clinical excellence, education, innovation, and scholarly activity. A unique opportunity exists to participate in the University's emerging Rapid Neurotherapeutics initiative, with potential collaboration in novel and rapid-acting therapeutics, addiction neuroscience, clinical trials, neuromodulation, biomarkers, and other innovative approaches to psychiatric and substance use disorders.